Toxoplasma gondii needs its host to be eaten by a cat. Infected rats lose their fear of cat urine. The standard explanation has been that the parasite disrupts the host's dopamine signaling indirectly — through inflammation, tissue damage, or cyst formation in the brain.
The mechanism is more direct than that. Toxoplasma encodes its own tyrosine hydroxylase, TgTH — an enzyme nearly identical to the mammalian enzyme that produces dopamine. The parasite manufactures dopamine inside the host's brain using its own molecular machinery.
Researchers engineered parasite lines with varying TgTH expression levels. The correlation was clean: more TgTH, more behavioral change. Rats with high-TgTH parasites showed significantly reduced aversion to cat odor. The dose-response curve confirms this is direct manipulation, not a side effect of infection.
What makes TgTH remarkable is its similarity to the host enzyme. The mammalian tyrosine hydroxylase is the rate-limiting step in dopamine synthesis — the most tightly regulated bottleneck in the reward system. TgTH is so structurally similar that the host's regulatory systems cannot distinguish parasite-produced dopamine from endogenous dopamine. There's no immune response to the enzyme. No metabolic flag. The foreign dopamine integrates seamlessly into the host's neurochemistry.
This is not molecular mimicry in the usual sense — a surface protein that evades immune detection. This is functional mimicry at the neurotransmitter level. The parasite doesn't merely look like the host. It speaks the host's chemical language fluently enough to rewrite behavioral priorities.
The through-claim: the most effective manipulation doesn't override the target system. It produces more of what the target system already uses. You don't need to hack the reward circuit if you can flood it with its own currency, minted by a factory the host doesn't know exists.